Ocumetics Strengthens Balance Sheet with $1.4 Million Debt Conversion Ahead of Key Clinical Milestones
Ocumetics Technology Corp. converts $1.4 million of debenture principal into equity, reducing debt by 35% and improving financial flexibility as it prepares for FDA submission.
